HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of a Th1 immune response and suppression of IgE via immunotherapy with a recombinant hybrid molecule encapsulated in liposome-protamine-DNA nanoparticles in a model of experimental allergy.

Abstract
Liposome-protamine-DNA nanoparticles (LPD) are safe, effective, and non-toxic adjuvants that induce Th1-like immune responses. We hypothesized that encapsulation of allergens into liposomes could be an appropriate option for immunotherapy. The present study evaluated the immunotherapeutic potential of a recombinant hybrid molecule (rHM) encapsulated in LPD nanoparticles in a murine model of Chenopodium album allergy. BALB/c mice were sensitized with the allergen in alum, and the immunotherapy procedure was performed by subcutaneous injections of LPD-rHM, rHM, or empty LPD at weekly intervals. Sensitized mice developed a Th2-biased immune response characterized by strong specific IgG1 and IgE production, IL-4, and the transcription factor GATA3 in spleen cell cultures. Treatment with the LPD-rHM resulted in a reduction in IgE and a marked increase in IgG2a. The LPD-rHM induced allergen-specific responses with relatively high interferon-gamma production, as well as expression of the transcription factor T-bet in stimulated splenocytes. In addition, lymphoproliferative responses were higher in the LPD-rHM-treated mice than in the other groups. Removal of the nanoparticles from the rHM resulted in a decrease in the allergen's immunogenicity. These results indicate that the rHM complexed with LPD nanoparticles has a marked suppressive effect on the allergic response and caused a shift toward a Th1 pathway.
AuthorsHamid Reza Nouri, Abdolreza Varasteh, Mahmoud Reza Jaafari, Janet M Davies, Mojtaba Sankian
JournalImmunologic research (Immunol Res) Vol. 62 Issue 3 Pg. 280-91 (Jul 2015) ISSN: 1559-0755 [Electronic] United States
PMID25957889 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • GATA3 Transcription Factor
  • Gata3 protein, mouse
  • Immunoglobulin G
  • Liposomes
  • Nanocapsules
  • Protamines
  • Recombinant Proteins
  • T-Box Domain Proteins
  • T-box transcription factor TBX21
  • Interleukin-4
  • Immunoglobulin E
  • Interferon-gamma
  • DNA
Topics
  • Animals
  • Chenopodium album (immunology)
  • DNA (pharmacology)
  • Female
  • GATA3 Transcription Factor (metabolism)
  • Hypersensitivity (drug therapy, immunology)
  • Immunoglobulin E (biosynthesis, immunology)
  • Immunoglobulin G (immunology)
  • Immunotherapy
  • Interferon-gamma (biosynthesis)
  • Interleukin-4 (metabolism)
  • Liposomes (pharmacology)
  • Mice
  • Mice, Inbred BALB C
  • Nanocapsules
  • Protamines (pharmacology)
  • Random Allocation
  • Recombinant Proteins
  • T-Box Domain Proteins (biosynthesis)
  • Th1 Cells (immunology)
  • Th2 Cells (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: